Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Chronic myeloid leukemia | R-HSA-9680350 | map05220 | iopromide | 3736 | drug-path |
| Circadian rhythm - mammal | R-HSA-400253 | 0 | iopromide | 3736 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | pyrithyldione | 4994 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | pyrithyldione | 4994 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | pyrithyldione | 4994 | drug-path |
| Axon guidance | R-HSA-422475 | map04360 | pyrithyldione | 4994 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | pyrithyldione | 4994 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | pyrithyldione | 4994 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | pyrithyldione | 4994 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | pyrithyldione | 4994 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | pyrithyldione | 4994 | drug-path |
| Shigellosis | 0 | map05131 | pyrithyldione | 4994 | drug-path |
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | pyrithyldione | 4994 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | pyrithyldione | 4994 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | pyrithyldione | 4994 | drug-path |
| Asthma | R-HSA-444620 | map05310 | pyrithyldione | 4994 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | pyrithyldione | 4994 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | pyrithyldione | 4994 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | iopamidol | 31378 | drug-path |
| Pancreatic cancer | R-HSA-9700206 | map05212 | iopamidol | 31378 | drug-path |